BioCentury
ARTICLE | Company News

Nutra Pharma, Zhong Xin Dong Tai Co. Ltd. deal

March 12, 2007 7:00 AM UTC

NPHC's ReceptoPharm Inc. division and Zhong Xin signed a nonbinding letter of intent to create a JV to develop and market NPHC's RPI-MN antiviral compound in China. Zhong Xin's Nanogene Biotechnology...